NEW YORK (GenomeWeb) – German genetic diagnostics firm Centogene is betting on whole-genome sequencing for improving the interpretation of genetic variants in patients with rare genetic disorders.
Last week, the company said it installed Illumina's HiSeq X sequencing platform at its clinical laboratory in Rostock in the Northeast of Germany in order to provide diagnostic whole-genome sequencing services.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
